Review:
Exome Sequencing (wes)
overall review score: 4.2
⭐⭐⭐⭐⭐
score is between 0 and 5
Whole Exome Sequencing (WES) is a genomic technique used to selectively sequence the protein-coding regions of the genome, known as exons. It aims to identify genetic variations and mutations that can be associated with various diseases, traits, and conditions. WES is widely used in research, clinical diagnostics, and personalized medicine to better understand genetic factors underlying health and disease.
Key Features
- Targets only the exonic regions (~1-2% of the genome), making it a cost-effective alternative to whole-genome sequencing
- High-throughput sequencing technology enabling rapid and comprehensive analysis of coding regions
- Useful for identifying rare genetic variants, mutations linked to inherited disorders, and cancer genomics
- Provides data that can be interpreted with established databases for known gene-disease associations
- Supports a range of applications including rare disease diagnosis, gene discovery, and pharmacogenomics
Pros
- Cost-effective compared to whole-genome sequencing
- High coverage of exonic regions improves mutation detection accuracy
- Facilitates diagnosis of genetic disorders in clinical settings
- Well-established methodology with extensive supporting resources
- Accelerates discovery of disease-associated genes
Cons
- Does not capture non-coding regions that may also affect health
- Potential for missing certain types of variants such as structural alterations or large indels
- Bias introduced during enrichment capture can affect uniformity of coverage
- Interpretation of variants remains complex and sometimes uncertain
- Not suitable for investigating regulatory or intergenic regions